Pharmaceutical manufacturing

French President Emmanuel Macron delivers a speech as he visits a plant of British-Swedish pharmaceutical group Astrazeneca in Dunkirk, northern France, Monday, Jan. 20, 2020. French President Emmanuel Macron is hosting 180 international business leaders later today at the Palace of Versailles in a bid to promote France's economic attractiveness despite over six weeks of crippling strikes over his government's planned pension changes.(Denis Charlet/Pool Photo via AP)
KNSS News
January 20, 2020 - 9:00 am
PARIS (AP) — France's president is taking on the role of salesman in chief for his strike-battered country. Emmanuel Macron used the splendor of the Palace of Versailles to woo international business leaders on Monday, insisting that his reforms are attracting investors despite six weeks of...
Read More
FILE - In this Dec. 24, 2019 photo, President Donald Trump speaks to members of the media following a Christmas Eve video teleconference with members of the military at his Mar-a-Lago estate in Palm Beach, Fla. As a candidate for the White House, Donald Trump repeatedly promised that he would “immediately” replace President Barack Obama’s health care law with a plan of his own that would provide “insurance for everybody.” Back then, Trump made it sound that his plan — “much less expensive and much better” than the Affordable Care Act — was imminent. And he put drug companies on notice that their pricing power no longer would be “politically protected.” Nearly three years after taking office, Americans still are waiting for Trump’s big reveal. (AP Photo/Andrew Harnik)
December 30, 2019 - 2:30 pm
WASHINGTON (AP) — As a candidate for the White House, Donald Trump repeatedly promised that he would “immediately” replace President Barack Obama’s health care law with a plan of his own that would provide “insurance for everybody.” Back then, Trump made it sound that his plan — “much less...
Read More
FILE - This June 15, 2018, file photo shows pharmaceuticals in North Andover, Mass. A revamped North American trade deal is nearing passage in Congress, giving both the White House and House Democrats cause to claim victory. There is relief, too, for farmers and businesses that wanted clearer rules governing the vast flow of goods among the United States, Canada and Mexico. But the pact left at least one surprising loser: The pharmaceutical industry, a near-invincible lobbying powerhouse in Washington. (AP Photo/Elise Amendola, File)
December 19, 2019 - 3:43 pm
A revamped North American trade deal nearing passage in Congress gives both the White House and Democrats a chance to claim victory and offers farmers and businesses clearer rules governing the vast flow of goods among the United States, Canada and Mexico. But the pact leaves at least one...
Read More
December 06, 2019 - 8:10 pm
WASHINGTON (AP) — A bipartisan Senate bill to curb prescription drug costs for Medicare recipients got a makeover Friday to lower copays and make it easier for seniors to budget for their expenses. The updated legislation unveiled by Sens. Chuck Grassley, R-Iowa, and Ron Wyden, D-Ore., would lower...
Read More
FILE - In this June 15, 2018, file photo, pharmaceuticals are seen in North Andover, Mass. A government report says prices for prescription drugs edged down 1% last year, driven by declines for generics and slow growth for brand-name medications. (AP Photo/Elise Amendola, File)
December 05, 2019 - 3:02 pm
WASHINGTON (AP) — Prices for prescription drugs edged down by 1% last year, a rare result driven by declines for generics and slow, low growth in the cost of brand-name medications, the government said Thursday. Though modest, it was the first such price drop in 45 years, according to nonpartisan...
Read More
November 21, 2019 - 7:59 pm
HONOLULU (AP) — Agrochemicals company Monsanto is pleading guilty to spraying a banned pesticide on its Maui fields in 2014. Monsanto, now owned by pharmaceutical company Bayer, is also agreeing to pay $10 million in an agreement over charges it unlawfully stored acute hazardous waste. The money...
Read More
FILE - In this Nov. 8, 2018 file photo, the U.S. Medicare Handbook is photographed in Washington. Medicare’s new prescription drug plan finder has a glitch that can steer unwitting seniors to coverage that costs much more than they need to pay. (AP Photo/Pablo Martinez Monsivais)
November 21, 2019 - 4:06 pm
WASHINGTON (AP) — Medicare’s revamped prescription plan finder can steer unwitting seniors to coverage that costs much more than they need to pay, according to people who help with sign-ups as well as program experts. Serving some 60 million Medicare recipients, the plan finder is the most commonly...
Read More
FILE - In this June 15, 2018, file photo, pharmaceuticals are seen in North Andover, Mass. Feeling a new urgency as the impeachment probe advances, the White House is ramping up its push to get a bill through Congress that curbs prescription drug costs. President Donald Trump’s top domestic policy adviser says the effort has advanced beyond anything seen in years even as he acknowledges the “current complications.” (AP Photo/Elise Amendola, file)
November 18, 2019 - 2:22 am
WASHINGTON (AP) — The White House is ramping up its push to get a bill through Congress that curbs prescription drug costs, feeling a new urgency as the impeachment investigation advances amid the 2020 election campaign. The effort has progressed beyond anything seen in years, says President Donald...
Read More
Edward McCarthy, center, works with fellow traders on the floor of the New York Stock Exchange, Tuesday, Oct. 29, 2019. Stocks are off to a slightly lower start on Wall Street as communications and energy companies fall. (AP Photo/Richard Drew)
October 29, 2019 - 4:53 pm
Technology companies led stocks lower on Wall Street Tuesday as a wobbly day of trading ended with modest losses for the market. Health care stocks jumped on stronger-than-expected reports from drugmakers, but losses by internet and media companies held the market in check. Companies have largely...
Read More
FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports financial earns Tuesday, Oct. 29, 2019. (AP Photo/Seth Wenig, File)
October 29, 2019 - 6:47 am
Big jumps in sales of Merck's top two blockbuster drugs drove revenue up 15%, but higher spending across the board pushed profits down 3% in the third quarter. Merck still easily beat Wall Street forecasts and boosted its forecast for the year. The quarter were dominated again by advanced cancer...
Read More

Pages